[Docetaxel in combination with epirubicin as the first-line chemotherapy for advanced and recurrent breast cancer: a multicenter phase II study].Keisei Anan, Kazuo Tamura, Shoshu Mitsuyama et al.|PubMed|2012Cited by 0